HEMACEM.BO stock traded in after hours on 02 Mar 2026 at INR 50.88, up 2.62% from the previous close as buyers tested a short-term recovery. The move follows a steep YTD decline of -35.26%, putting the stock in an oversold setup compared with its 50-day average of INR 53.09 and 200-day average of INR 62.34. Volume was light at 564.00 shares, so this looks like an initial bounce rather than a confirmed reversal. We outline a concise oversold-bounce plan, risk points, and price targets for traders on the BSE in India.

HEMACEM.BO stock quick facts and price context

Hemadri Cements Ltd. (HEMACEM.BO) trades on the BSE in India at INR 50.88 with a market cap of INR 339369600.00 and 6,670,000.00 shares outstanding. Day range was INR 48.00–51.60, year high INR 85.05 and year low INR 44.00. The stock sits below its 50-day average (INR 53.09) and 200-day average (INR 62.34), signaling pressure that supports an oversold-bounce strategy.

Technical setup: oversold bounce levels and signals

Price action shows a short bounce off the intraday low INR 48.00 with limited volume (564.00), so momentum is tentative. Key levels for traders: immediate support INR 48.00, stop-loss zone INR 46.00, near resistance INR 51.60, and critical resistance at the 50-day average INR 53.09. The stock’s YTD decline of -35.26% and 6-month change -24.56% indicate oversold conditions that can produce relief rallies but require tight risk controls.

Fundamental snapshot and sector context for HEMACEM.BO stock

Hemadri Cements operates in the Construction Materials industry within Basic Materials in India. Public filings show no reported EPS or P/E data currently, so traditional valuation ratios are limited. Sector peers show mixed performance; large cement companies trade at higher multiples, underscoring Hemadri’s smaller capitalization and higher volatility. Recent volume and price trends suggest the market is pricing company-specific and sector headwinds into the current level.

Meyka Grade and model forecast for HEMACEM.BO

Meyka AI rates HEMACEM.BO with a score out of 100: 62.29 / Grade B / Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a yearly target INR 118.41, a 132.71% implied upside from INR 50.88; quarterly model prints INR 40.86. Forecasts are model-based projections and not guarantees. Use these alongside company filings and market news before acting.

Trading plan and HEMACEM.BO price targets

For an oversold-bounce trade, consider a short-term target INR 58.00 (approx. 14.00% upside), medium target at the 200-day average INR 62.34 (approx. 22.53% upside), and a longer-term model target INR 118.41. Risk control: set stop-loss between INR 46.00 and INR 44.00 depending on risk tolerance. Keep position size small given light average volume (1,375.00) and intermittent liquidity on BSE.

Risks, catalysts and what to watch in HEMACEM.BO news

Primary risks include continued sector weakness, low liquidity with average volume 1,375.00, and absence of recent earnings data (next reported earnings date previously 03 May 2025). Catalysts that could confirm a sustained reversal: higher-than-normal volume, margin improvement news, or sector demand pickup. Track regulatory changes, fuel-cost swings, and company releases on the Hemadri website and BSE for updates.

Final Thoughts

Key takeaways on HEMACEM.BO stock: the after-hours uptick to INR 50.88 on 02 Mar 2026 is a textbook oversold bounce after a deep YTD decline of -35.26%. Trading shows low liquidity (volume 564.00), so intraday strength needs confirming with volume above the average 1,375.00. Meyka AI’s forecast model projects a yearly target of INR 118.41, implying 132.71% upside versus the current price; short-term tactical targets are INR 58.00 and INR 62.34. These projections are model-based and not guarantees; combine them with fresh earnings, sector data and on-exchange volume before scaling positions. As an AI-powered market analysis platform, Meyka AI highlights this setup as a potential short-term trade for disciplined traders, while longer-term investors should wait for clearer volume-led confirmation and improved fundamentals.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.